학술논문
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
Document Type
Article
Author
Fisher, M.J.; Shih, C.-S.; Rhodes, S.D.; Armstrong, A.E.; Angus, S.P.; Robertson, K.A.; Bijangi-Vishehsaraei, K.; Shih, C.-S.; Armstrong, A.E.; Clapp, D.W.; Smith, A.E.; Bessler, W.K.; He, Y.; Park, S.-J.; Mund, J.A.; Jiang, L.; Wolters, P.L.; Dombi, E.; Widemann, B.C.; Zhang, C.; Johnson, G.L.; Packer, R.J.; Allen, J.C.; Ullrich, N.J.; Goldman, S.; Gutmann, D.H.; Plotkin, S.R.; Rosser, T.; Robinson, C.T.; Cutter, G.R.; Korf, B.R.; Blakeley, J.O.
Source
In: Nature Medicine . (Nature Medicine, January 2021, 27(1):165-173)
Subject
Language
English
ISSN
1546170X
10788956
10788956